Net Income (TTM) Chart

Historical Net Income (TTM) Data

View and export this data back to 1984. Upgrade now.
Date Value
June 30, 2023 13.05B
March 31, 2023 12.72B
December 31, 2022 17.94B
September 30, 2022 19.16B
June 30, 2022 18.37B
March 31, 2022 19.83B
December 31, 2021 20.88B
September 30, 2021 17.88B
June 30, 2021 17.77B
March 31, 2021 15.12B
December 31, 2020 14.71B
September 30, 2020 16.99B
June 30, 2020 15.18B
March 31, 2020 17.17B
December 31, 2019 15.12B
September 30, 2019 14.15B
June 30, 2019 16.33B
March 31, 2019 14.68B
December 31, 2018 15.30B
September 30, 2018 1.542B
June 30, 2018 1.372B
March 31, 2018 1.245B
December 31, 2017 1.30B
September 30, 2017 15.83B
June 30, 2017 16.34B
Date Value
March 31, 2017 16.50B
December 31, 2016 16.54B
September 30, 2016 15.94B
June 30, 2016 15.03B
March 31, 2016 15.55B
December 31, 2015 15.41B
September 30, 2015 14.72B
June 30, 2015 16.11B
March 31, 2015 15.92B
December 31, 2014 16.32B
September 30, 2014 17.32B
June 30, 2014 15.55B
March 31, 2014 15.06B
December 31, 2013 13.83B
September 30, 2013 12.88B
June 30, 2013 12.86B
March 31, 2013 10.44B
December 31, 2012 10.85B
September 30, 2012 8.504B
June 30, 2012 8.738B
March 31, 2012 10.11B
December 31, 2011 9.672B
September 30, 2011 11.40B
June 30, 2011 11.61B
March 31, 2011 12.28B

Net Income Definition

Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.

Read full definition.

Net Income (TTM) Range, Past 5 Years

12.72B
Minimum
Mar 2023
20.88B
Maximum
Dec 2021
16.44B
Average
16.33B
Median
Jun 2019

Net Income (TTM) Benchmarks

Amgen Inc 7.979B
Eli Lilly and Co 6.498B
Merck & Co Inc 3.111B
Pfizer Inc 21.47B
AbbVie Inc 8.685B